X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (270371) 270371
Book Review (31316) 31316
Publication (11720) 11720
Newsletter (9653) 9653
Newspaper Article (7163) 7163
Book Chapter (1882) 1882
Conference Proceeding (1611) 1611
Dissertation (745) 745
Magazine Article (622) 622
Trade Publication Article (260) 260
Book / eBook (233) 233
Web Resource (178) 178
Government Document (104) 104
Reference (52) 52
Paper (30) 30
Transcript (27) 27
Data Set (10) 10
Journal / eJournal (8) 8
Report (4) 4
Streaming Video (3) 3
Presentation (2) 2
Library Holding (1) 1
Spoken Word Recording (1) 1
Technical Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (206574) 206574
humans (172201) 172201
male (80158) 80158
animals (71511) 71511
female (71357) 71357
middle aged (44418) 44418
adult (41449) 41449
blood platelets (35399) 35399
hematology (35250) 35250
platelets (33611) 33611
aged (31914) 31914
abridged index medicus (28042) 28042
blood platelets - metabolism (23763) 23763
platelet aggregation - drug effects (20649) 20649
mice (20013) 20013
rats (19320) 19320
blood platelets - drug effects (19284) 19284
platelet count (19244) 19244
platelet aggregation inhibitors - therapeutic use (18104) 18104
peripheral vascular disease (17978) 17978
biochemistry & molecular biology (17609) 17609
platelet aggregation (16815) 16815
research (15433) 15433
platelet-derived growth factor (15347) 15347
time factors (15256) 15256
cardiac & cardiovascular systems (15072) 15072
blood platelets - physiology (13897) 13897
risk factors (13783) 13783
cell biology (13689) 13689
pharmacology & pharmacy (13622) 13622
cells, cultured (12722) 12722
treatment outcome (12710) 12710
thrombosis (12541) 12541
analysis (12270) 12270
activation (11989) 11989
surgery (11875) 11875
in vitro techniques (11693) 11693
adolescent (11117) 11117
blood (10998) 10998
expression (10884) 10884
aspirin (10324) 10324
platelet (10019) 10019
aggregation (9591) 9591
platelet activation (9327) 9327
rabbits (9298) 9298
inflammation (9148) 9148
platelet aggregation inhibitors - pharmacology (9138) 9138
oncology (9112) 9112
cells (8606) 8606
dose-response relationship, drug (8594) 8594
care and treatment (8571) 8571
aged, 80 and over (8356) 8356
medicine, general & internal (8141) 8141
immunology (8077) 8077
proteins (7961) 7961
plasma (7762) 7762
kinetics (7736) 7736
aspirin - therapeutic use (7710) 7710
ticlopidine - analogs & derivatives (7584) 7584
disease (7523) 7523
medicine, research & experimental (7442) 7442
cancer (7424) 7424
retrospective studies (7389) 7389
child (7284) 7284
platelet aggregation inhibitors - administration & dosage (7278) 7278
health aspects (7130) 7130
clopidogrel (7031) 7031
signal transduction (6949) 6949
prospective studies (6870) 6870
thrombocytopenia (6752) 6752
pregnancy (6652) 6652
phosphorylation (6616) 6616
risk (6611) 6611
inhibition (6524) 6524
in-vitro (6469) 6469
platelet-rich plasma (6401) 6401
prognosis (6387) 6387
mortality (6262) 6262
therapy (6243) 6243
physiological aspects (6168) 6168
platelet aggregation inhibitors - adverse effects (6147) 6147
atherosclerosis (6121) 6121
flow cytometry (6050) 6050
thrombin (5944) 5944
blood platelets - immunology (5915) 5915
medicine (5868) 5868
platelet transfusion (5842) 5842
blood platelets - cytology (5759) 5759
molecular sequence data (5750) 5750
blood platelets - enzymology (5635) 5635
article (5562) 5562
adenosine diphosphate - pharmacology (5555) 5555
patients (5501) 5501
medical research (5435) 5435
blood coagulation (5392) 5392
disease models, animal (5386) 5386
collagen (5368) 5368
dogs (5364) 5364
anticoagulants - therapeutic use (5319) 5319
drug therapy, combination (5304) 5304
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (182) 182
Online Resources - Online (68) 68
Collection Dvlpm't (Acquisitions) - Vendor file (10) 10
Collection Dvlpm't (Acquisitions) - Closed Orders (7) 7
UofT at Scarborough - Stacks (4) 4
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (3) 3
UofT at Mississauga - Stacks (3) 3
Chemistry (A D Allen) - Stacks (2) 2
Dentistry (Harry R Abbott) - Stacks (2) 2
UTL at Downsview - May be requested (2) 2
Gerstein Science - Periodical Stacks (1) 1
Gerstein Science - Theses (1) 1
Media Commons - Audio Visual (1) 1
Mt Sinai Hospital - Online (1) 1
Scarborough Hospital - General (1) 1
Scarborough Hospital - Online (1) 1
St. Michael's Hospital - Stacks (1) 1
University Archives - Archives (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (263785) 263785
German (5888) 5888
French (4118) 4118
Russian (3989) 3989
Japanese (3816) 3816
Chinese (2793) 2793
Spanish (1604) 1604
Italian (1410) 1410
Polish (1165) 1165
Portuguese (459) 459
Korean (383) 383
Czech (366) 366
Turkish (277) 277
Hungarian (225) 225
Dutch (174) 174
Danish (144) 144
Swedish (131) 131
Norwegian (96) 96
Croatian (91) 91
Romanian (86) 86
Ukrainian (80) 80
Serbian (77) 77
Slovak (72) 72
Hebrew (67) 67
Bulgarian (62) 62
Finnish (45) 45
Persian (39) 39
Lithuanian (25) 25
Slovenian (8) 8
Bosnian (7) 7
Indonesian (7) 7
Icelandic (6) 6
Arabic (4) 4
Afrikaans (3) 3
Greek (3) 3
Estonian (2) 2
Gaelic (1) 1
Latvian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal
Transfusion, ISSN 0041-1132, 06/2005, Volume 45, Issue 6, pp. 911 - 919
BACKGROUND: Several strategies are being developed to reduce the risk of pathogen transmission associated with platelet (PLT) transfusion. STUDY DESIGN AND... 
STORAGE | PROMOTE PROCOAGULANT ACTIVITY | MEMBRANE-GLYCOPROTEINS | FLOW CONDITIONS | HEMOSTATIC EFFECTIVENESS | BLEEDING-TIME | ARTERY SUBENDOTHELIUM | ANNEXIN-V | TRANSFUSION MEDICINE | BLOOD-FLOW | HEMATOLOGY | P-Selectin - radiation effects | Platelet Adhesiveness - radiation effects | Blood Platelets - radiation effects | Temperature | Fibronectins - radiation effects | Platelet Glycoprotein GPIIb-IIIa Complex - radiation effects | Blood Preservation | Humans | Annexin A5 - drug effects | Platelet Membrane Glycoprotein IIb - analysis | Riboflavin - pharmacology | Blood Platelets - physiology | Fibrinogen - radiation effects | Antigens, CD - analysis | Flow Cytometry | Ultraviolet Rays | von Willebrand Factor - drug effects | Time Factors | Blood Platelets - cytology | Platelet Glycoprotein GPIIb-IIIa Complex - drug effects | Plateletpheresis | Annexin A5 - analysis | Platelet Glycoprotein GPIb-IX Complex - radiation effects | P-Selectin - analysis | Blood Platelets - drug effects | Lysosome-Associated Membrane Glycoproteins | Antigens, CD - radiation effects | Fibrinogen - drug effects | Platelet Glycoprotein GPIb-IX Complex - drug effects | Platelet Membrane Glycoprotein IIb - drug effects | von Willebrand Factor - analysis | Fibronectins - analysis | Platelet Glycoprotein GPIb-IX Complex - analysis | Blood Platelets - chemistry | Platelet Transfusion | Annexin A5 - radiation effects | Platelet Membrane Glycoprotein IIb - radiation effects | Antigens, CD - drug effects | Platelet Glycoprotein GPIIb-IIIa Complex - analysis | Fibronectins - drug effects | Platelet Adhesiveness - drug effects | P-Selectin - drug effects | Platelet Count | von Willebrand Factor - radiation effects | Fibrinogen - analysis | Platelet Activation - drug effects | Platelet Activation - radiation effects | Index Medicus
Journal Article
PLoS ONE, ISSN 1932-6203, 10/2016, Volume 11, Issue 10, pp. e0163006 - e0163006
Thioredoxin (Trx) is an oxidoreductase with important physiological function. Imbalances in the NADPH/thioredoxin reductase/thioredoxin system are associated... 
PROTEIN-DISULFIDE-ISOMERASE | FORMATION IN-VIVO | ENDOTHELIUM | MULTIDISCIPLINARY SCIENCES | BONDS | REDUCTASE | RECEPTOR | CANCER | ASSOCIATION | EXPRESSION | PROGRESSION | Platelet Function Tests - methods | Benzothiazoles - pharmacology | Humans | Imidazoles - pharmacology | Hydroquinones - pharmacology | Platelet Adhesiveness - drug effects | Receptors, Collagen - metabolism | Thrombosis - metabolism | Thioredoxins - pharmacology | Ristocetin - pharmacology | Blood Platelets - metabolism | Platelet Membrane Glycoproteins - metabolism | Platelet Aggregation Inhibitors - pharmacology | Blood Coagulation Tests - methods | Disulfides - pharmacology | Platelet Activation - drug effects | Platelet Aggregation - drug effects | Thrombosis - drug therapy | Blood Platelets - drug effects | von Willebrand Factor - metabolism | Thiols | Collagen | Von Willebrand factor | Physiological aspects | Oxidoreductases | Thioredoxin | Thrombosis | Blood clot | Neurosciences | Peptides | Oxidoreductase | Clinical trials | Activation | Kinases | Cell surface | Proteins | Receptors | Blood platelets | Chemical bonds | Physiology | Oxidation | Inhibition | Agglutination | NADP | Thromboembolism | Enzymes | Medical research | Pharmacology | Rutin | Substrates | Blood clots | Endothelium | Pathology | Valence | Inhibitors | Acids | Proteomics | Ligands | Platelets | Binding sites | Ristocetin | Cancer | Apoptosis | Reductase | Index Medicus
Journal Article
Circulation, ISSN 0009-7322, 05/2011, Volume 123, Issue 17, pp. 1891 - 1899
Background-Blocking of glycoprotein VI-dependent pathways by interfering in vascular collagen sites is commonly seen as an attractive target for an... 
stroke | platelet aggregation inhibitors | platelet adhesion | glycoprotein VI | platelet aggregation | CARDIAC & CARDIOVASCULAR SYSTEMS | FAB FRAGMENT | THROMBUS FORMATION | ACUTE CORONARY SYNDROME | ADHESION | CLOPIDOGREL | IN-VIVO | PERIPHERAL VASCULAR DISEASE | SOLUBLE GPVI | MICE | HEMATOLOGY | ANTITHROMBOTIC PROTECTION | EXPRESSION | Injections, Intravenous | Cricetulus | Recombinant Fusion Proteins - adverse effects | Humans | Male | Immunoglobulin Fc Fragments - administration & dosage | Dose-Response Relationship, Drug | Young Adult | Platelet Aggregation Inhibitors - administration & dosage | Platelet Membrane Glycoproteins - administration & dosage | Adult | Platelet Membrane Glycoproteins - adverse effects | Platelet Aggregation - drug effects | Platelet Aggregation Inhibitors - pharmacokinetics | Immunoglobulin Fc Fragments - adverse effects | Recombinant Fusion Proteins - administration & dosage | CHO Cells | Platelet Aggregation Inhibitors - adverse effects | Hemostasis - drug effects | Platelet Membrane Glycoproteins - pharmacokinetics | Cricetinae | Glycoproteins - administration & dosage | Collagen - administration & dosage | Animals | Platelet Count | Recombinant Fusion Proteins - pharmacokinetics | Aggregation | Safety and security measures | Blood platelets | Hemostasis | Patient outcomes | Atherosclerosis | Dosage and administration | Research | Drug therapy | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2015, Volume 135, Issue 6, pp. 1424 - 1432
Anaphylaxis is an acute, severe, life-threatening multisystem allergic reaction resulting from the sudden systemic release of biochemical mediators and... 
Allergy and Immunology | Allergy | signaling | mediators | receptor antagonists | anaphylaxis | platelet-activating factor | mast cells | acetylhydrolase | platelets | sepsis | PHOSPHOLIPASE A INHIBITOR | CLINICAL-TRIAL | IMMUNOLOGY | FACTOR ACETYLHYDROLASE ACTIVITY | PHASE-II TRIAL | FACTOR PAF | FACTOR RECEPTOR ANTAGONIST | DOUBLE-BLIND | HUMAN NASAL AIRWAY | CORONARY-ARTERY-DISEASE | SEVERE SEPSIS | Blood Platelets - pathology | Blood Platelets - immunology | Humans | Platelet Activation - immunology | Platelet Activating Factor - immunology | Eosinophils - immunology | 1-Alkyl-2-acetylglycerophosphocholine Esterase - immunology | Receptors, G-Protein-Coupled - immunology | 1-Alkyl-2-acetylglycerophosphocholine Esterase - genetics | Sepsis - pathology | Asthma - immunology | Anaphylaxis - immunology | Eosinophils - pathology | Platelet Aggregation - genetics | Neutrophils - pathology | Mast Cells - immunology | Platelet Membrane Glycoproteins - immunology | Sepsis - immunology | Platelet Aggregation - immunology | Signal Transduction | Anaphylaxis - pathology | Gene Expression Regulation | Neutrophils - immunology | Platelet Activating Factor - genetics | Platelet Membrane Glycoproteins - genetics | Asthma - genetics | Sepsis - genetics | Anaphylaxis - genetics | Platelet Activation - genetics | Mast Cells - pathology | Receptors, G-Protein-Coupled - genetics | Asthma - pathology | Enzymes | Immune response | Anaphylaxis | Permeability | Metabolites | Analysis | Proteins | Antigens | Blood platelets | E coli | Rodents | Preeclampsia | Lipids | Smooth muscle | Carbon | Biological activity | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Thrombosis and Haemostasis, ISSN 1538-7933, 08/2017, Volume 15, Issue 8, pp. 1646 - 1654
Background: After three miscarriages, a 39-year-old woman gave birth, with a 1-year interval, to two severely thrombocytopenic neonates (4 x10(9) L-1 and 33... 
GPI | neonatal alloimmune | thrombocytopenia | complex | platelet | platelet glycoprotein | human platelet antigens | platelets | platelet glycoprotein IX | platelet GPIb–IX complex | POINT MUTATION | REACTIVE ANTIBODIES | ALPHA INTEGRIN | IMMUNE THROMBOCYTOPENIA | BERNARD-SOULIER-SYNDROME | PERIPHERAL VASCULAR DISEASE | FETOMATERNAL ALLOIMMUNE THROMBOCYTOPENIA | SEQUENCE ALIGNMENTS | HEMATOLOGY | platelet GPIb-IX complex | ALLOANTIGEN | BETA INTEGRIN | ANTIBODY-SPECIFIC IMMOBILIZATION | Humans | Isoantibodies - blood | Platelet Glycoprotein GPIb-IX Complex - metabolism | Thrombocytopenia, Neonatal Alloimmune - diagnosis | Transfection | DNA Mutational Analysis | Thrombocytopenia, Neonatal Alloimmune - blood | Fatal Outcome | HEK293 Cells | Female | Infant, Newborn | Serologic Tests | Genetic Predisposition to Disease | Platelet Transfusion | Antigens, Human Platelet - blood | Treatment Outcome | Heredity | Antigens, Human Platelet - immunology | Pregnancy | Phenotype | Thrombocytopenia, Neonatal Alloimmune - therapy | Antigens, Human Platelet - genetics | Pedigree | Platelet Glycoprotein GPIb-IX Complex - genetics | Thrombocytopenia, Neonatal Alloimmune - genetics | Mutation | Platelet Glycoprotein GPIb-IX Complex - immunology | Infants (Newborn) | Thrombocytopenia | Antigens | Transfusion | Blood platelets | Cesarean section | Neonates | Flow cytometry | Nucleotide sequence | Fetuses | Immobilization | Gestation | Polymerase chain reaction | Isoimmunization | Genotyping | Gene frequency | Alleles | Monoclonal antibodies | Alloantibodies | Children | Platelets | DNA sequencing | Index Medicus
Journal Article
1997, Handbook of experimental pharmacology, ISBN 9783540619970, Volume 126., xxviii, 753
Book
2005, Contemporary cardiology, ISBN 1588292444, xi, 397
A cutting-edge review of the latest findings on the complexities of platelet function and the various means of inhibiting platelet clot formation. The authors... 
physiopathology | Blood platelets | therapy | physiology | Diagnosis | Blood platelet disorders | Examination | Clinical & internal medicine | Medicine & Public Health | Cardiology
Book
Circulation: Cardiovascular Interventions, ISSN 1941-7640, 12/2012, Volume 5, Issue 6, pp. 797 - 804
Background-Ticagrelor and prasugrel provide stronger platelet inhibition compared with clopidogrel. Direct pharmacodynamic comparison between them has not yet... 
Prasugrel | Pharmacology | Platelets | Ticagrelor | Platelet reactivity | prasugrel | CARDIAC & CARDIOVASCULAR SYSTEMS | PLATO TRIAL | platelet reactivity | ticagrelor | DOSE CLOPIDOGREL | platelets | PERCUTANEOUS CORONARY INTERVENTION | INHIBITION | TASK-FORCE | pharmacology | TREATMENT PLATELET REACTIVITY | OUTCOMES | ASSOCIATION | AGGREGATION | ARTERY-DISEASE | Piperazines - administration & dosage | Single-Blind Method | Myocardial Infarction - blood | Prasugrel Hydrochloride | Thiophenes - therapeutic use | Prospective Studies | Purinergic P2Y Receptor Antagonists - administration & dosage | Thiophenes - adverse effects | Humans | Middle Aged | Receptors, Purinergic P2Y12 - drug effects | Male | Thiophenes - administration & dosage | Greece | Myocardial Infarction - therapy | Purinergic P2Y Receptor Antagonists - adverse effects | Time Factors | Adenosine - adverse effects | Adenosine - therapeutic use | Platelet Aggregation Inhibitors - administration & dosage | Platelet Function Tests | Female | Platelet Aggregation - drug effects | Blood Platelets - drug effects | Platelet Aggregation Inhibitors - therapeutic use | Receptors, Purinergic P2Y12 - metabolism | Purinergic P2Y Receptor Antagonists - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Drug Administration Schedule | Linear Models | Treatment Outcome | Piperazines - therapeutic use | Adenosine - administration & dosage | Piperazines - adverse effects | Blood Platelets - metabolism | Adenosine - analogs & derivatives | Least-Squares Analysis | Aged | Percutaneous Coronary Intervention - adverse effects | Index Medicus
Journal Article
13.